Evidence map›Paper›PMID 30168501›Full record

ArticleLa Medicina del lavoro2018

Exposure to airborne particles associated with the handling of graphene nanoplatelets.

Andrea Spinazzè, Andrea Cattaneo, Francesca Borghi, Luca Del Buono, Davide Campagnolo, Sabrina Rovelli, Domenico Maria Cavallo

Abstract read
In one paragraph

Article in La Medicina del lavoro, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andrea SpinazzèDipartimento di Scienza e Alta Tecnologia, Università degli Studi dell'Insubria. andrea.spinazze@uninsubria.it.
Andrea Cattaneo
Francesca Borghi
Luca Del Buono
Davide Campagnolo
Sabrina Rovelli
Domenico Maria Cavallo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is recognized that engineering control measures are needed to reduce occupational exposure to engineered nanomaterials (NMs): of these, fume hoods are among the most widespread collective protection equipment used while handling NMs in occupational settings.  It is known that in some circumstances, handling NMs in fume hoods can result in a significant release of NMs.

objectiveTo assess the effectiveness of fume hoods in reducing exposure while handling graphene nanoplatelets and to define the conditions that result in a lower dispersion of particles and thus less operator exposure.

methodsAn experimental protocol was established to monitor the variations of airborne particle concentrations while handling graphene in fume hoods (transferring and pouring). The measurement locations were at the laboratory, inside the hood and at operator's breathing zone. Handling tasks were performed under different operating conditions: the variable factors included hood face velocity and sash height.

resultsResults of this study indicate that the handling of graphene nanoplatelets may pose a potential risk of contamination of the work environment and hence exposure of the involved operators, if adequate control measures are not taken. In fact, when inadequate or not sufficiently cautionary operational conditions were utilized, non-negligible increases in airborne graphene particle concentrations during the nanomaterial manipulation phases were observed.

conclusionsSome operating conditions (e.g., face velocity, sash height) can be adjusted to avoid relevant personal exposure conditions and contamination of the work environment by NMs, thus ensuring safer conditions.

Indexed as

Air Pollutants, OccupationalGraphiteRespiratory Protective DevicesHumansInhalation ExposureNanoparticlesOccupational ExposureAir Pollutants, OccupationalGraphite

Identifiers

PMID30168501
PMCPMC7682168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.